#novavax

[dillyt]

Great news for uninsured adults in the USA who want a COVID-19 booster! It now appears that ALL CVS locations are now active participants in the Bridge Access Program. The Bridge Access Program gives out free Covid-19 vaccinations to 18+ adults who otherwise can't afford one, so if you have a CVS near you, please go get one! For others who don't have a CVS near them, please go to vaccines.gov, click on "Find Covid-19 vaccines", fill out which vaccines you prefer (you can mix different vaccines if you have to so i reccomend just marking all of them for the age groups you need), and when the next page loads mark the "Bridge Access Program Participant" option to see only locations that are Bridge Access Program participants. Hopefully, other places that aren't CVS will start participating soon, so just check back every so often to see if there are any updates. The CDC Bridge Access Program website also has more details on what locations will be participating, but only CVS is appearing as an active participant on the vaccines.gov location finder at the moment.

[justinspoliticalcorner]

FDA approves new Covid-19 vaccines in US but limits who can get them

Agency authorizes shots for those 65 and older, with young people eligible if they have underlying medical conditions

Oliver Milman at The Guardian:

The US Food and Drug Administration (FDA) has approved updated Covid-19 vaccines but has placed new restrictions on who can get them. The agency has authorized Covid vaccines for people 65 and older, who are known to be more at risk from serious illnesses from Covid infections. Younger people, though, will only be eligible if they have an underlying medical condition that makes them particularly vulnerable. This means that the upcoming fall and winter seasons will be the first where the US government hasn’t recommended widespread Covid vaccinations. Robert F Kennedy Jr, the US health secretary, said in a post on Twitter/X that Covid vaccine “mandates” under Joe Biden are now rescinded and that the vaccines will be available to those at high risk. For children, Kennedy said that the Moderna vaccine is approved for those older than six months, the Pfizer vaccine for those older than five years and the Novavax shot for those older than 12. “These vaccines are available for all patients who choose them after consulting with their doctors,” Kennedy said in his social media post. “The American people demanded science, safety, and common sense. This framework delivers all three.”

The FDA gave approval to a new round of COVID vaccines, but with limits as to who is eligible to get them. This broke a promise of RFK Jr.’s to not take away COVID vaccines form people.

Those aged 65 and over are eligible for the new COVID shots without restrictions, but those under 65 are eligible if they have at least one co-morbidity.

Among children, the Moderna vaccine is approved for 6 months and older, Pfizer 5 and older, and Novavax 12 and over.

See Also:

NBC News: FDA approves fall Covid shots, but with new restrictions

HuffPost: The FDA Has Approved COVID Shots, But Not For Everyone. Here’s What You Need To Know.

[covid-safer-hotties]

This is what community care looks like: You meet people where they are and try to help them forward.

[pandemic-info]

Novavax is here!

Good news! Many pharmacies across the U.S. received Novavax shipments yesterday, Sept. 9 2024.

Call your local and confirm with a human.

CVS Tips:

Use this with the automated system to find out if yours carries it: "Vaccine availability > COVID-19 > Details"

Or hit 8003 right away to talk to a human

See also:

Schedule your COVID-19 Vaccine Appointment | Novavax

Vaccine finder updated today, but not yet functional: Schedule an appointment at your preferred pharmacy for the updated Novavax COVID-19 Va

All #Novavax info:

[cosmonautistic]

The amount of spam / bot accounts sharing anti-vax sentiment in the tags is frustrating. I'm blocking them all on sight. All the websites seem like a virus waiting to happen which is almost ironic. Reminder not to click on their links so that your devices aren't infected.

If you want, type the headline into a search engine but don't click on random links from people you don't know or trust.

[a-typical]

Is an mRNA or a protein-based COVID-19 vaccine better?

The vaccine that is best is the one that’s available to you and the one that you’re willing to get!

I’ve heard chatter about some people believing that Novavax provides better protection against COVID-19, and there just aren’t data to support that.

Novavax trials and real-world evidence collection lagged substantially behind the mRNA vaccines, so trying to compare measured vaccine effectiveness is comparing apples to oranges. Approximately 3.2 billion doses of mRNA vaccines have been administered compared to 2.6 million doses of Novavax vaccine.

All you need to know is that all of the COVID-19 vaccines demonstrated over 90% effectiveness in their initial clinical trials. All options protect against severe disease, hospitalization, and death. All of the available options have been reviewed by experts and deemed to be safe, comparably effective, and beneficial.

Novavax may have slightly lower reactogenicity compared to mRNA vaccines. Reactogenicity refers to symptoms that occur from the immune response: low grade fever, headache, lethargy, injection site soreness, lymphadenopathy (swollen lymph nodes), etc.

Will JN.1 vaccine formulation provide measurably different protection than the more closely matched KP.2 formulation that we will see in the mRNA vaccines? It is too hypothetical to know. That will be impacted by how much virus circulates within a community and how much more SARS-CoV-2 mutates as a result of genetic drift because of that spread.

What can reduce the potential mutation and spread of SARS-CoV-2? Getting vaccinated.

[willowreader]

Three immunizations with Novavax’s protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2 - npj Vaccines

The immune responses to Novavax’s licensed NVX-CoV2373 nanoparticle Spike protein vaccine against SARS-CoV-2 remain incompletely understood.

It is almost impossible to find this vaccine in Canada. Why?

[thoughtportal]

August 30, 2024

Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of age and older. It includes a monovalent (single) component that corresponds to the Omicron variant JN.1 strain of SARS-CoV-2. 

“The COVID-19 vaccines have had a tremendous positive impact on public health and vaccination continues to be the most effective method for COVID-19 prevention,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. “COVID-19 continues to be a very real risk for many people, and we encourage individuals to consider getting an updated COVID-19 vaccine when eligible. Today’s authorization provides an additional COVID-19 vaccine option that meets the FDA’s standards for safety, effectiveness and manufacturing quality needed to support emergency use authorization.”

This authorization follows the FDA’s recent approvals and authorizations of updated mRNA COVID-19 vaccines for 2024-2025 manufactured by ModernaTX Inc. and Pfizer Inc.

What You Need to Know

Individuals 12 years of age and older who have never been vaccinated with any COVID-19 vaccine are eligible to receive two doses of this updated vaccine, 3 weeks apart.

Individuals who have been vaccinated only with one dose of any Novavax COVID-19 vaccine are eligible to receive one dose of the updated Novavax COVID-19 vaccine at least 3 weeks after the previous dose.  

Those who have been vaccinated with a prior formula of a COVID-19 vaccine from another manufacturer or with two or more doses of a prior formula of the Novavax COVID-19 vaccine are eligible to receive a single dose of the updated Novavax COVID-19 vaccine at least 2 months after the last dose of a COVID-19 vaccine.

The FDA assessed manufacturing and nonclinical data to support the change to the 2024-2025 formula. The updated vaccine is manufactured using a similar process as previous formulas of this vaccine. Individuals who receive this vaccine may experience similar side effects as those reported by individuals who received previous formulas of this COVID-19 vaccine and as described in the fact sheets. 

The FDA has determined that the updated Novavax COVID-19 vaccine has met the statutory criteria for issuance of an EUA, including that the known and potential benefits of the vaccine outweigh its known and potential risks in individuals 12 years of age and older. 

As part of today’s action, the Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) is no longer authorized for use.

The FDA granted the emergency use authorization of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) to Novavax Inc. of Gaithersburg, Maryland.